CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 866	$ 1,383	$ 2,014	$ 3,517
General and administrative	1,048	1,164	2,109	2,632
Total operating expenses	1,914	2,547	4,123	6,149
Operating loss	(1,914)	(2,547)	(4,123)	(6,149)
Total other income (expense), net	68	(2)	123	(2)
Net loss	$ (1,846)	$ (2,549)	$ (4,000)	$ (6,151)
Net loss per common share:
Net loss per common share, Basic	$ (3.62)	$ (13.27)	$ (7.85)	$ (38.52)
Net loss per common share, Diluted	$ (3.62)	$ (13.27)	$ (7.85)	$ (38.52)
Weighted average number of common shares outstanding
Weighted average number of common shares outstanding, Basic	510,188	192,054	509,542	159,663
Weighted average number of common shares outstanding, Diluted	510,188	192,054	509,542	159,663